Background: Inflammation plays an important role in tumor progression. Predicting survival
is remarkably difficult in patients with gastric cancer receiving neoadjuvant chemotherapy …

The platelet-to-lymphocyte ratio (PLR) is a useful prognostic factor in several cancers.
However, the prognostic role of PLR in esophageal cancer remains controversial. The aim of …

Mean platelet volume as a predictive marker for venous thromboembolism in patients treated
for Hodgkin lymphoma - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Thyroid cancer is the most prevalent endocrine cancer and is evident in nearly 5% of thyroid
nodules. The correlation between mean platelet volume (MPV) and many other cancer types …

Background Solid tumors are a common cause of secondary (reactive) thrombocytosis, a
paraneoplastic syndrome that is also a prognostic factor for various cancers. However, cutoff …

Background and aims Several studies were conducted to explore the prognostic value of
platelet-to-lymphocyte ratio (PLR) in pancreatic cancer and have reported contradictory …

Activated platelets promote cancer progression and metastasis. Nevertheless, the
prognostic value of platelet indices in melanoma had been rarely reported. The aim of this …

The interaction between cancer cells and platelets has been known for a long time. Although
platelet indices have been also investigated in several clinical settings, it has not been …

Background: Increasing amounts of evidence suggest patient-related systemic inflammatory
response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a …

Background The prognostic and clinicopathological significance of the platelet to
lymphocyte ratio (PLR) has been studied in various cancers. However, studies examining …